suspect device / changes to their computerized systems / therapy for postmenopausal symptoms / estrogen-containing products / Treatment of Vasomotor Symptoms / drug products / treatment of moderate to severe vasomotor symptoms / /
National Institute of Health / FDA’s Center for Devices / Food and Drug Administration / Availability AGENCY / office of Management and Budget / MDUFMA / Center for Devices / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Ophthalmic Devices Panel / Medicare / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / Congress / MDR PO / Medical Devices Advisory Committee / Division of Drug Information / Division of Dockets Management / Center for Drug Evaluation and Research / Meeting AGENCY / /
Person
Beverly Chernaik Rothstein / Peter J. Pitts / Carolyn M. Clancy / / /
Position
Associate Commissioner / Director / Private / reporter / Acting Deputy Director for Policy / initial reporter / /
7490 Federal Register / Vol. 69, No[removed]Tuesday, February 17, [removed]Notices measuring patient experiences within the health care system of the United